Michael Scolaro

Michael Scolaro

Oct 06, 2017

Group 6 Copy 216
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Targeted Drug Delivery by using Magnetic Nanoparticles

What if we could use a novel approach for delivering currently injectable drugs to the body without syringes...

Can cockroaches help us cure tularemia?

Tularemia is a deadly disease caused by the bacterium Francisella tularensis (Ft). This bacterium is also a...

Mosquitoes as Flying Syringes: The Solution to Rapid Zika Monitoring

Yes, mosquitoes are flying syringes! They sample human blood as a normal part of their life cycle. We can take...

Backer Badge Funded